The citalopram CIT-MD-18 pediatric depression trial: Deconstruction of medical ghostwriting, data mischaracterisation and academic malfeasance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The citalopram CIT-MD-18 pediatric depression trial: Deconstruction of medical ghostwriting, data mischaracterisation and academic malfeasance

Published:2016-03-16 Issue:1 Volume:28 Page:33-43
ISSN:0924-6479
Container-title:International Journal of Risk & Safety in Medicine
language:
Short-container-title:JRS

Author:

Jureidini Jon N.¹,Amsterdam Jay D.²,McHenry Leemon B.³

Affiliation:

1. Critical and Ethical Mental Health Research Group, University of Adelaide, Adelaide, Australia

2. Depression Research Unit, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA

3. Department of Philosophy, California State University, Northridge, CA, USA

Publisher

IOS Press

Subject

Public Health, Environmental and Occupational Health,Health Policy,General Medicine

Reference21 articles.

1. Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data;Whittington;Lancet,2004

2. Suicide rates in short-term randomized controlled trials of newer antidepressants;Hammad;J Clin Psychopharmacol,2006

3. Trends in depression and antidepressant prescribing in children and adolescents: A cohort study in The Health Improvement Network (THIN);Wijlaars;PLoS One,2012

4. Publication bias, with a focus on psychiatry: Causes and solutions;Turner;CNS Drugs,2013

5. Clinical trials and drug promotion: Selective reporting of study 329;Jureidini;Int J Risk Saf Med,2008

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the strategies opioid manufacturers used to recruit health professionals and encourage overprescribing: an analysis of industry documents;BMC Public Health;2024-08-08

2. Issues arising from the study design, conduct, and promotion of clinical trials funded by opioid manufacturers: a review of internal pharmaceutical industry documents;Evidence & Policy;2023-11

3. O USO DE ANTIDEPRESSIVOS EM CRIANÇAS E ADOLESCENTES;Revista Saúde Dos Vales;2023-11-01

4. Off-Label Use vs Off-Label Marketing;JACC: Basic to Translational Science;2023-03

5. Industry strategies to market opioids to children and women in the USA: a content analysis of internal industry documents from 1999 to 2017 released in State of Oklahoma v. Purdue Pharma, L.P.et al;BMJ Open;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3